🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Describe the efficacy of the use of topical besifloxacin in reducing the co...
Status
Completed
Location
Institute of Ophthalmology, Conde de Valenciana Foundation
Start Date
2017-01
Trial ID
NCT04542759
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of Besiv...
Status
Terminated
Location
Bausch & Lomb Incorporated
Start Date
2011-05
Trial ID
NCT01330355
Treatments Being Tested
To assess the safety and efficacy of PACK-CXL (photoactivated chromophore f...
Status
Completed
Location
University of Geneva
Start Date
2016-03
Trial ID
NCT02717871
Treatments Being Tested
This is a study to investigate a novel drug candidate for the treatment of ...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00348348
Treatments Being Tested
This is a study comparing a new treatment for bacterial keratitis (also kno...
Status
Completed
Location
McGill Academic Eye Center
Start Date
2015-09
Trial ID
NCT02497365
Treatments Being Tested
The purpose of this study is to compare drug concentrations in aqueous humo...
Status
Completed
Location
Bucci Laser Vision Institute
Start Date
2011-05
Trial ID
NCT01296191
Treatments Being Tested
The purpose of this study is to demonstrate that Besivance is equal to Viga...
Status
Completed
Location
Ophthalmology Associates
Start Date
2010-09
Trial ID
NCT01455233
To evaluate the clinical and microbial efficacy of ISV-403 administered thr...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00622908
This is a multi-center, open-label, single dose/multiple dose, pharmacokine...
Status
Completed
Location
Cornerstone Eyecare
Start Date
2006-10
Trial ID
NCT00407589
Treatments Being Tested
This study is being conducted to evaluate the intraocular penetration of Mo...
Status
Completed
Location
The Wilmer Eye Institute at Johns Hopkins University
Start Date
2009-09
Trial ID
NCT00924729
Treatments Being Tested